Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1957 1
1958 1
1975 1
1976 2
1977 3
1978 4
1979 1
1981 4
1982 4
1983 3
1984 3
1985 3
1986 9
1987 2
1988 10
1989 7
1990 7
1991 6
1992 4
1993 5
1994 8
1995 7
1996 10
1997 8
1998 5
1999 10
2000 7
2001 9
2002 9
2003 8
2004 5
2005 6
2006 8
2007 8
2008 8
2009 10
2010 8
2011 12
2012 11
2013 8
2014 12
2015 6
2016 6
2017 8
2018 1
2019 6
2020 21
2021 20
2022 1
Text availability
Article attribute
Article type
Publication date

Search Results

303 results
Results by year
Filters applied: . Clear all
Page 1
Erlotinib versus standard chemotherapy as first-line treatment for European patients with advanced EGFR mutation-positive non-small-cell lung cancer (EURTAC): a multicentre, open-label, randomised phase 3 trial.
Rosell R, Carcereny E, Gervais R, Vergnenegre A, Massuti B, Felip E, Palmero R, Garcia-Gomez R, Pallares C, Sanchez JM, Porta R, Cobo M, Garrido P, Longo F, Moran T, Insa A, De Marinis F, Corre R, Bover I, Illiano A, Dansin E, de Castro J, Milella M, Reguart N, Altavilla G, Jimenez U, Provencio M, Moreno MA, Terrasa J, Muñoz-Langa J, Valdivia J, Isla D, Domine M, Molinier O, Mazieres J, Baize N, Garcia-Campelo R, Robinet G, Rodriguez-Abreu D, Lopez-Vivanco G, Gebbia V, Ferrera-Delgado L, Bombaron P, Bernabe R, Bearz A, Artal A, Cortesi E, Rolfo C, Sanchez-Ronco M, Drozdowskyj A, Queralt C, de Aguirre I, Ramirez JL, Sanchez JJ, Molina MA, Taron M, Paz-Ares L; Spanish Lung Cancer Group in collaboration with Groupe Français de Pneumo-Cancérologie and Associazione Italiana Oncologia Toracica. Rosell R, et al. Among authors: porta r. Lancet Oncol. 2012 Mar;13(3):239-46. doi: 10.1016/S1470-2045(11)70393-X. Epub 2012 Jan 26. Lancet Oncol. 2012. PMID: 22285168 Clinical Trial.
The added value of pirfenidone to fight inflammation and fibrotic state induced by SARS-CoV-2 : Anti-inflammatory and anti-fibrotic therapy could solve the lung complications of the infection?
Ferrara F, Granata G, Pelliccia C, La Porta R, Vitiello A. Ferrara F, et al. Among authors: la porta r. Eur J Clin Pharmacol. 2020 Nov;76(11):1615-1618. doi: 10.1007/s00228-020-02947-4. Epub 2020 Jun 27. Eur J Clin Pharmacol. 2020. PMID: 32594204 Free PMC article. Review.
Feasibility and Efficacy of the Pulmonary Rehabilitation Program in a Rehabilitation Center: CASE REPORT OF A YOUNG PATIENT DEVELOPING SEVERE COVID-19 ACUTE RESPIRATORY DISTRESS SYNDROME.
Pancera S, Galeri S, Porta R, Pietta I, Bianchi LNC, Carrozza MC, Villafañe JH. Pancera S, et al. Among authors: porta r. J Cardiopulm Rehabil Prev. 2020 Jul;40(4):205-208. doi: 10.1097/HCR.0000000000000529. J Cardiopulm Rehabil Prev. 2020. PMID: 32609464 Free PMC article. Review.
Definition of Synchronous Oligometastatic Non-Small Cell Lung Cancer-A Consensus Report.
Dingemans AC, Hendriks LEL, Berghmans T, Levy A, Hasan B, Faivre-Finn C, Giaj-Levra M, Giaj-Levra N, Girard N, Greillier L, Lantuéjoul S, Edwards J, O'Brien M, Reck M, Smit EF, Van Schil P, Postmus PE, Ramella S, Lievens Y, Gaga M, Peled N, Scagliotti GV, Senan S, Paz-Ares L, Guckenberger M, McDonald F, Ekman S, Cufer T, Gietema H, Infante M, Dziadziuszko R, Peters S, Porta RR, Vansteenkiste J, Dooms C, de Ruysscher D, Besse B, Novello S. Dingemans AC, et al. Among authors: porta rr. J Thorac Oncol. 2019 Dec;14(12):2109-2119. doi: 10.1016/j.jtho.2019.07.025. Epub 2019 Aug 6. J Thorac Oncol. 2019. PMID: 31398540 Free article.
Biopolymers as Food Packaging Materials.
Porta R, Sabbah M, Di Pierro P. Porta R, et al. Int J Mol Sci. 2020 Jul 13;21(14):4942. doi: 10.3390/ijms21144942. Int J Mol Sci. 2020. PMID: 32668678 Free PMC article.
Remdesivir and COVID-19.
Ferrara F, Porta R, D'Aiuto V, Vitiello A. Ferrara F, et al. Among authors: porta r. Ir J Med Sci. 2021 Aug;190(3):1237-1238. doi: 10.1007/s11845-020-02401-5. Epub 2020 Oct 17. Ir J Med Sci. 2021. PMID: 33068241 Free PMC article. No abstract available.
Sacubitril, valsartan and SARS-CoV-2.
Vitiello A, La Porta R, Ferrara F. Vitiello A, et al. Among authors: la porta r. BMJ Evid Based Med. 2020 Jul 27:bmjebm-2020-111497. doi: 10.1136/bmjebm-2020-111497. Online ahead of print. BMJ Evid Based Med. 2020. PMID: 32719054 No abstract available.
Transglutaminases as biotechnological tools.
Mariniello L, Porta R. Mariniello L, et al. Among authors: porta r. Prog Exp Tumor Res. 2005;38:174-91. doi: 10.1159/000084240. Prog Exp Tumor Res. 2005. PMID: 15746536 Review. No abstract available.
COVID-19 vaccines and decreased transmission of SARS-CoV-2.
Vitiello A, Ferrara F, Troiano V, La Porta R. Vitiello A, et al. Among authors: la porta r. Inflammopharmacology. 2021 Oct;29(5):1357-1360. doi: 10.1007/s10787-021-00847-2. Epub 2021 Jul 19. Inflammopharmacology. 2021. PMID: 34279767 Free PMC article. Review.
303 results